SCHEMBL6161955

SCHEMBL6161955

CC(C)(C)OC(=O)NC(Cc1ccccc1)C(=O)N1CC(O)C(O)C1

nearest known ligand 0.71

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.62
MAPK1 P28482 1/20 0.58
CTSS P25774 3/20 0.57
CTSK P43235 2/20 0.57
CTSL P07711 1/20 0.57
CTSB P07858 1/20 0.57
ACE P12821 2/20 0.55
HRH2 P25021 1/20 0.54
HRH1 P35367 1/20 0.54
PABPC1 P11940 1/20 0.54
ATM Q13315 1/20 0.53
AKT1 P31749 1/20 0.53
ADORA1 P30542 1/20 0.51
SCN9A Q15858 1/20 0.50
PARP1 P09874 1/20 0.50
DPP8 Q6V1X1 1/20 0.50
DPP9 Q86TI2 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6162598 1.00 KMT2A (0.62) KMT2AMAPK1CTSSCTSKCTSL
SCHEMBL6162594 1.00 KMT2A (0.62) KMT2AMAPK1CTSSCTSKCTSL
SCHEMBL6624940 1.00 KMT2A (0.62) KMT2AMAPK1CTSSCTSKCTSL
SCHEMBL6624367 1.00 KMT2A (0.62) KMT2AMAPK1CTSSCTSKCTSL
SCHEMBL6162796 0.93 KMT2A (0.62) KMT2AMAPK1CTSSCTSKCTSL
SCHEMBL2375730 0.89 KMT2A (0.60) KMT2AMAPK1CTSSCTSKCTSL
SCHEMBL2375725 0.89 KMT2A (0.60) KMT2AMAPK1CTSSCTSKCTSL
SCHEMBL8113033 0.88 KMT2A (0.61) KMT2AMAPK1CTSSCTSKCTSL
SCHEMBL8113029 0.88 KMT2A (0.61) KMT2AMAPK1CTSSCTSKCTSL
SCHEMBL6165554 0.87 KMT2A (0.66) KMT2AMAPK1CTSSCTSKCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1134213-B1 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER (US) 2005-11-02 EP disclosed
EP-0832065-B1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER (US) 2001-10-10 EP disclosed
EP-1134213-A2 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER INC. (US) 2001-09-19 EP disclosed
US-6277877-B1 GLYCOGEN PHOSPHORYLASE INHIBITOR; ANTIDIABETIC AGENTS PFIZER, INC. 2001-08-21 US disclosed
US-6107329-A HYPOTENSIVE AGENTS; CARDIOVASCULAR DISORDERS PFIZER, INC. (US) 2000-08-22 US disclosed
WO-1996039384-A1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER, INC. (US) 1996-12-12 WO disclosed